Paper42410643
Beyond the ethics deflection: Why patient burden is a scientific review question, not just an IRB concern.
Stakic S. Res Involv Engagem, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Beyond the ethics deflection: Why patient burden is a scientific review question, not just an IRB concern. Papers, record 42410643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42410643
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Beyond the ethics deflection: Why patient burden is a scientific review question, not just an IRB concern.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References10
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37167582 | Patient Advocates and Researchers as Partners in Cancer Research: A Winning Combination. | Am Soc Clin Oncol Educ Book | 2023 | https://conductscience.org/library/papers/37167582 | PubMed |
| 2 | 23034025 | The prevention and treatment of missing data in clinical trials. | N Engl J Med | 2012 | https://conductscience.org/library/papers/23034025 | PubMed |
| 3 | 26714555 | Predicting Low Accrual in the National Cancer Institute's Cooperative Group Clinical Trials. | J Natl Cancer Inst | 2016 | https://conductscience.org/library/papers/26714555 | PubMed |
| 4 | 30487232 | Impact of patient and public involvement on enrolment and retention in clinical trials: systematic review and meta-analysis. | BMJ | 2018 | https://conductscience.org/library/papers/30487232 | PubMed |
| 5 | 27249699 | The Role of Clinical Trial Participation in Cancer Research: Barriers, Evidence, and Strategies. | Am Soc Clin Oncol Educ Book | 2016 | https://conductscience.org/library/papers/27249699 | PubMed |
| 6 | 26042632 | Institutional Review Boards: Purpose and Challenges. | Chest | 2015 | https://conductscience.org/library/papers/26042632 | PubMed |
| 7 | 28968170 | Broadening Eligibility Criteria to Make Clinical Trials More Representative: American Society of Clinical Oncology and Friends of Cancer Research Joint Research Statement. | J Clin Oncol | 2017 | https://conductscience.org/library/papers/28968170 | PubMed |
| 8 | 24568690 | Patient engagement in research: a systematic review. | BMC Health Serv Res | 2014 | https://conductscience.org/library/papers/24568690 | PubMed |
| 9 | 20406924 | Equipoise lost: ethics, costs, and the regulation of cancer clinical research. | J Clin Oncol | 2010 | https://conductscience.org/library/papers/20406924 | PubMed |
| 10 | 25475878 | Unsuccessful trial accrual and human subjects protections: an empirical analysis of recently closed trials. | Clin Trials | 2015 | https://conductscience.org/library/papers/25475878 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42410643
GET https://conductscience.org/api/papers/v1/42410643/authors